NCT07162467 Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia. Status ENROLLING_BY_INVITATION Phase N/A
NCT07155096 Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity Status ENROLLING_BY_INVITATION Phase NA
NCT07153835 Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study Status NOT_YET_RECRUITING Phase PHASE4
NCT07145918 A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia Status RECRUITING Phase PHASE2
NCT07139171 Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia Status RECRUITING Phase N/A
NCT07122895 Sex Differences in NMDA-enhancing Treatment of Schizophrenia Status RECRUITING Phase PHASE2
NCT07116694 Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder Status COMPLETED Phase PHASE2
NCT07114874 NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia Status RECRUITING Phase PHASE3
NCT07105111 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Status RECRUITING Phase PHASE4
NCT07105098 NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia Status RECRUITING Phase PHASE3
NCT07102069 Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia Status COMPLETED Phase N/A
NCT07101094 Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) Status RECRUITING Phase N/A
NCT07075237 Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia Status NOT_YET_RECRUITING Phase PHASE4
NCT07061288 A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia Status RECRUITING Phase PHASE1
NCT07051746 Effectiveness of Traditional Chinese Metacognitive Training (MCT) in Patients With Schizophrenia, Depression, or Bipolar Disorder Attending a Psychiatric Day Hospital in Taiwan Status COMPLETED Phase NA
NCT07045142 Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients Status RECRUITING Phase PHASE3
NCT07038876 A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07011953 A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07006935 REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health) Status NOT_YET_RECRUITING Phase NA